Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Only Gurls LLC is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single prosecution matter is assigned to 1 distinct examiner and is being reviewed within 1 distinct art unit. This suggests a highly focused technical direction for the company's current patent activities in this field.
The busiest examiner for this portfolio is CUNNINGCHEN, KATHLEEN MARY, who is currently overseeing 1 pending office action. As this is the only pending action for the company, the outcome of the prosecution depends entirely on the interaction with this specific examiner. Practitioners should prioritize understanding the preferences and historical patterns of this 1 distinct examiner to move the case toward allowance.
The concentration of the 1 pending office action in 1 distinct art unit simplifies the administrative burden of the prosecution process. There are no conflicting examiner viewpoints or varying art unit standards to navigate. The entire current effort is centered on the 1 pending office action under the review of CUNNINGCHEN, KATHLEEN MARY, allowing for a streamlined and efficient legal strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CUNNINGCHEN, KATHLEEN MARY | 1 | 61.4% | +61.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18745376 | METHOD FOR OPTIMIZING DRUG SELECTION | CUNNINGCHEN, KATHLEEN MARY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18745376 | METHOD FOR OPTIMIZING DRUG SELECTION | CUNNINGCHEN, KATHLEEN MARY | — |
| Art Unit | Apps |
|---|---|
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18745376 | METHOD FOR OPTIMIZING DRUG SELECTION | CUNNINGCHEN, KATHLEEN MARY | 1646 | §102§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOnly Gurls LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Kathleen Mary Cunningchen has the most, with 1 of Only Gurls LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.